Online citations, reference lists, and bibliographies.
← Back to Search

Design And In Vivo Evaluation Of An Oral Delivery System For Insulin

M. Marschütz, P. Caliceti, A. Bernkop-Schnürch
Published 2004 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
AbstractPurpose. To develop an oral controlled release system for insulin. Methods. The polymer-inhibitor conjugates carboxymethylcellulose (CMC)-Bowman-Birk inhibitor and CMC-elastatinal were homo- genized with polycarbophil-cysteine conjugate, insulin, and mannitol, compressed to 2 mg microtablets and enteric coated with a polymethacrylate. The protective effect of this delivery system for insulin towards enzymatic degradation, as well as the release profile, was evaluated in vitro. In addition, the effect of the dosage form on glucose levels of diabetic mice was determined. Results. Tablets containing the CMC-inhibitor conjugates showed a strong protective effect for insulin. Whereas 91.6 ± 7.4% (mean ± SD, n = 3) of insulin in the dosage form without the inhibitor conjugates has been degraded within 3 h of incubation in an artificial intestinal fluid containing physiological concentrations of trypsin, chymotrypsin, and elastase, 49.7 ± 5.5% (mean ± SD, n = 3) of insulin remained stable in the delivery system containing the polymer-inhibitor conjugates. Additionally, polycarbophil-cysteine (PCP-Cys) provides high cohesiveness of the dosage form, due to the formation of inter- as well as intramolecular disulfide bonds within the polymer matrix. According to this, a controlled release of insulin could be achieved over a time period of 10 h. Furthermore, in vivo studies in diabetic mice showed a decrease in basal glucose levels of 20% to 40% during a time period of 80 h. Conclusions. Mucoadhesive polymer-inhibitor conjugates might represent a promising excipient in delivery systems for oral (poly)peptide delivery.
This paper references
Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.
H. Tozaki (1997)
Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems.
A. Bernkop-Schnürch (2000)
Absorption of protein via the intestinal wall. A quantitative model.
E. Ziv (1987)
Recent developments in insulin delivery techniques. Current status and future potential.
F. Kennedy (1991)
The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.
J. Cleland (1993)
Polymers with Thiol Groups: A New Generation of Mucoadhesive Polymers?
A. Bernkop-Schnürch (2004)
Physical stabilization of insulin by glycosylation.
Miroslav Baudyš (1995)
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
M. Marschütz (2000)
Enhanced Intestinal Absorption of Insulin in Rats in the Presence of Sodium 5-Methoxysalicylate
T. Nishihata (1981)
Development of controlled drug release systems based on thiolated polymers.
A. Bernkop-Schnürch (2000)
Receptor-binding region of insulin
R. A. Pullen (1976)
Synthesis and characterisation of mucoadhesive thiolated polymers.
A. Bernkop-Schnürch (2000)
Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin.
A. Bernkop-Schnürch (1999)
Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
C. Lehr (1994)
moting effect of the new chymotrypsin inhibitor KD - 488 on the intestinal absorption of insulin in rats and dogs
G. H. Schwarz Bernkop-Schnürch (1985)
hanced intestinal absorption of insulin in the presence of sodium 5 - methoxysalicylate
I. Morishita Morishita (1981)
Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
M. Morishita (1993)
current status and future potential
F. P. Kennedy. Recent developments in insulin deliver techniques (1991)
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
H. Tozaki (1997)
Enzymatic barriers for GI peptide and protein delivery.
J. Woodley (1994)
Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.
Z. Chap (1985)
Differential Effects of Anionic, Cationic, Nonionic, and Physiologic Surfactants on the Dissociation, α-Chymotryptic Degradation, and Enteral Absorption of Insulin Hexamers
Z. Shao (2004)
Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides
A. Bernkop-Schnürch (1997)
Enzymatic barriers for GI peptide and protein delivery.
Woodley Jf (1994)
A new generation of mucoadhesive polymers? Pharm
A. Bernkop-Schnürch (1999)
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
A Case for Oral Insulin Therapy in the Prevention of Diabetic Micro- and Macroangiopathy
G. Gwinup (1990)
Promoting effect of the new chymotrypsin inhibitor FK‐448 on the intestinal absorption of insulin in rats and dogs
S. Fujii (1985)

This paper is referenced by
Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.
V. Grabovac (2008)
The Synthesis of Poly N-acetyl iodo Glucosamine and its Gelation of Blood.
Maria Ina (2013)
Thiomers: a new generation of mucoadhesive polymers.
A. Bernkop-Schnürch (2005)
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
M. Morishita (2006)
Bioresponsive nanoparticles based on poly(amidoamine)s for protein delivery
Grégory Coué (2011)
Ligand-Mediated Gastrointestinal Targeting
J. Woodley (2002)
Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.
H. Xu (2002)
Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin.
D. Guggi (2003)
Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion.
D. Guggi (2004)
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
Fang-Yi Su (2012)
Thiomers: Impact of in situ cross‐linkers on mucoadhesive properties
Hung Thanh Lam (2017)
Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
A. Bernkop-Schnürch (2004)
Evaluation of the inhibition effect of thiolated poly(acrylates) on vaginal membrane bound aminopeptidase N and release of the model drug LH‐RH
C. Valenta (2002)
Controlled release systems for insulin delivery
Liang-Yin Chu (2005)
Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin.
Hui-Peng Lim (2014)
Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective
H. Hoyer (2010)
The Potential of Thiolated Polymers for Peptide Drug Delivery
J. Kawadkar (2010)
Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles.
Lichen Yin (2008)
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
A. Bernkop-Schnürch (2003)
Mucoadhesive Polymers: Basics, Strategies, and Future Trends
A. Bernkop-Schnürch (2013)
Oral administration of insulin included in fine W/O/W emulsions to rats
M. Shima (2006)
Oral biodrug delivery using cell-penetrating peptide.
E. Khafagy (2012)
Pharmacokinetic analysis and formulation development of therapeutic proteins
Kimberley Temeca Hill (2004)
Improved paracellular uptake by the combination of different types of permeation enhancers.
D. Guggi (2005)
Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles
N. Ahmad (2016)
Carboxyl-functionalized derivatives of carboxymethyl cellulose: towards advanced biomedical applications
Asja Pettignano (2019)
Animal models for evaluation of oral delivery of biopharmaceuticals
Stine Harloff-Helleberg (2017)
Natural anionic polymer acts as highly efficient trypsin inhibitor based on an electrostatic interaction mechanism.
Y. Lv (2014)
Absorption of arginine-vasopressin and arginine-vasotocin in small intestine of the frog Rana temporaria
N. Prutskova (2012)
Oral insulin delivery systems based on complexation polymer hydrogels
M. Morishita (2006)
Orally active insulin mimics: where do we stand now?
M. Balasubramanyam (2007)
In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
N. Reix (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar